You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
McKesson
Dow
Express Scripts
McKinsey

Last Updated: April 15, 2021

DrugPatentWatch Database Preview

INTRON A Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for INTRON A

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Roswell Park Cancer InstitutePhase 1/Phase 2
Editas Medicine, Inc.Phase 1/Phase 2
AllerganPhase 1/Phase 2

See all INTRON A clinical trials

Recent Litigation for INTRON A

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Bay State Milling Company v. Arcadia Biosciences, Inc.2019-04-01
Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC2018-12-19
Boston Heart Diagnostics Corporation v. MD Labs, Inc.2018-01-04

See all INTRON A litigation

PTAB Litigation
PetitionerDate
Regeneron Pharmaceuticals, Inc.2019-09-20
Regeneron Pharmaceuticals, Inc.2019-05-14
Baylor College of Medicine2018-04-18

See all INTRON A litigation

Pharmacology for INTRON A

Company Disclosures: US Patents for INTRON A

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Madison, NJ) 2002-11-19 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Biogen N.V. (Curacao, AN) 2002-07-23 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2039-03-29 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2014-10-11 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Hoffman-La Roche Inc. (Nutley, NJ) Genentech, Inc. (South San Francisco, CA) 2020-08-26 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Schering Corporation (Madison, NJ) 2002-11-19 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for INTRON A

These patents were identified by searching patent claims

Supplementary Protection Certificates for INTRON A

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
91648 Luxembourg   Start Trial 91648, EXPIRES: 20150220
91013 Luxembourg   Start Trial
132010901806069 Italy   Start Trial AUTHORISATION NUMBER(S) AND DATE(S): EU/1/09/609/001-002, 20100125
PA2017037 Lithuania   Start Trial PRODUCT NAME: NUSINERSENAS ARBA JO DRUSKOS; REGISTRATION NO/DATE: EU/1/17/1188/001 20170530
2003C/006 Belgium   Start Trial PRODUCT NAME: MOROCTOCOG ALFA; REGISTRATION NO/DATE: EU/1/99/103/001 19990413
132017000128699 Italy   Start Trial PRODUCT NAME: NUSINERSEN O SUOI SALI(SPINRAZA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1188, 20170601
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Johnson and Johnson
Harvard Business School
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.